MARKET

CMOPF

CMOPF

Cosmo Pharmaceuticals Nv
OTCPK
97.17
NaN%
Closed 09:30 05/22 EDT
OPEN
--
PREV CLOSE
97.17
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
159.28
52 WEEK LOW
95.00
MARKET CAP
1.58B
P/E (TTM)
-366.5409
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CMOPF last week (0511-0515)?
Weekly Report · 5d ago
Cosmo completes Phase II recruitment for novel ulcerative colitis therapy
TipRanks · 5d ago
Cosmo Announces Completion of Phase II Enrolment in Distal Ulcerative Colitis Program
Newsfile · 5d ago
COSMO Pharmaceuticals N.V. (0RGI) Gets a Buy from Kepler Capital
TipRanks · 05/13 01:39
Weekly Report: what happened at CMOPF last week (0504-0508)?
Weekly Report · 05/11 10:45
COSMO Pharmaceuticals N.V. (0RGI) Receives a Buy from Kepler Capital
TipRanks · 05/09 01:40
Weekly Report: what happened at CMOPF last week (0427-0501)?
Weekly Report · 05/04 10:41
Kepler Capital Sticks to Its Buy Rating for COSMO Pharmaceuticals N.V. (0RGI)
TipRanks · 04/30 01:49
More
About CMOPF
Cosmo Pharmaceuticals N.V. is a pharmaceutical company. The Company is focused on gastrointestinal (GI) diseases, dermatology, and healthtech. Its development pipeline includes Distal Ulcerative Colitis, Bile Acid Diarrhea, Solid Tumors, and AI Augmented Endoscopy. The Company's developed products include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, which is used for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, which is a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo, which is used for the treatment of travelers’ diarrhea (TD); Methylene Blue MMX, which is a diagnostic drug to improve precancerous and cancerous lesion detection during colonoscopy, and Winlevi, which is used for the treatment of acne. It also develops medical devices to assist with clinical decision-making.

Webull offers Cosmo Pharmaceuticals NV stock information, including OTCPK: CMOPF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMOPF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMOPF stock methods without spending real money on the virtual paper trading platform.